PHS
NTGN

PFM Health Sciences’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

PFM Health Sciences’s Portfolio NTGN Stock Details NTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-121,848
Closed -$578K – 108
2019
Q2 		$578K Sell
121,848
-300,548
-71% -$1.68M 0.01% 85
2019
Q1 		$2.73M Sell
422,396
-556,606
-57% -$2.91M 0.06% 89
2018
Q4 		$4.92M Buy
979,002
+165
+0% +$1.16K 0.13% 78
2018
Q3 		$7.34M Buy
978,837
+4,076
+0.4% +$45.2K 0.11% 107
2018
Q2 		$10.8M Buy
+974,761
New +$13.3M 0.17% 99

Other funds holding NTGN

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PFM Health Sciences's NTGN Position: Q3 2019 in Review

PFM Health Sciences sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q3 2019, closing a stake of 121,848 shares — an estimated $578K sold.

PFM Health Sciences first reported a position in NTGN in Q2 2018 and held it in 5 quarters. The position peaked at $10.8M in Q2 2018. 58 funds tracked by Wall St. Rank hold NTGN as of Q3 2019.

  • PFM Health Sciences reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • PFM Health Sciences sold 121,848 Neon Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $578K.
  • PFM Health Sciences first reported a position in Neon Therapeutics, Inc. Common Stock in Q2 2018 and held it in 5 quarters.
  • PFM Health Sciences's Neon Therapeutics, Inc. Common Stock position peaked at $10.8M in Q2 2018.
  • 58 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q3 2019.

Based on PFM Health Sciences's 13F filing for Q3 2019, filed 14 Nov 2019.